Anhui Biochem United Pharmaceutical Co Ltd (ABUP) is a leading Hi-Tech enterprise that specializes in research, production and marketing of anti-HIV and anti-HBV chiral drugs in China. It was formed in 2007 by Anhui Biochem Pharmaceutical that was established in 2003, and QVT Fund. ABUP is located in Taihe Country, Fuyang City, Auhui Province. It has more than four hundred staff members with a total asset of over RMB 510 million, covering an area of 50.74 acres.

ABUP masters international core technology of chiral drugs and has one of biggest production and most complete variety of anti-HBV and anti-HIV/AIDS API manufacturing base in China, which starts the precedent of domestic anti-HBV and anti-HIV products and ends the history of a long term of dependence on import antiviral. ABUP has two owned subsidiaries: Anhui Biochem Bio-Pharmaceutical Co., Ltd. and Anhui Biochem Medical Sales Co., Ltd. It has formed a complete industry chain from API R&D, synthesis to formulation production and marketing. ABUP insists on independent research and development, and maintains close relationships with many domestic universities and research institutes. Meanwhile, it introduces new varieties of anti-HBV/HIV drugs. At present, ABUP has most of the AIDS antiviral "cocktail" drugs, such as Lamivudine, Zidovidine, Nevirapine, Tenofovir Disoproxil Fumarat, Emtricitabine, Efavirenz and their intermediates. ABUP also has Lamivudine, Enticavir and Tenofovir Disoproxil Fumarat. These drugs are most effective anti-HBV drugs in the world. Besides, our products also contain digestant Lafutidine and antidepressant Selegiline Hydrochloride Capsules. China ChemPharm Brand Summit nominated ABUP as the "2011 Top Ten Brand of Innovation Chempharm Enterprise" on April 21, 2011. Good reputation, efficient management and quality products, make the company's products export to international and domestic markets. ABUP has got the registration certificate of Canada, India, Russia and Brazil and other countries, and will carry out the U.S. FDA, EU and WHO on-site audit. ABUP will finally achieve the vision of "Respect life; Stop HBV &HIV/AIDS" by tightly grasping the historic opportunities of development, adhering to the objective of the company and sticking to the mission of the company.

Related Categories

Sales Markets

Middle East Region (e.g. UAE); Asia; Africa; Central America (e.g. Mexico); Central/South America; East Asia (e.g. China, Japan, Korea); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)

Primary business activity

Manufacturer/Innovator